Roivant Sciences ROIV Stock-Based Comp
Stock-Based Comp at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Roivant Sciences's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Roivant Sciences's stock-based comp?
- Roivant Sciences (ROIV) reported stock-based comp of $77.17M in Q1 2026.
- How has Roivant Sciences's stock-based comp changed year-over-year?
- Roivant Sciences's stock-based comp decreased by 7.6% year-over-year, from $83.49M to $77.17M.
- What is the long-term trend for Roivant Sciences's stock-based comp?
- Over 4 years (2021 to 2025), Roivant Sciences's stock-based comp has grown at a -11.5% compound annual growth rate (CAGR), from $564.96M to $346.17M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.